戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              PI and the resulting production of IL-1beta was found to
2                                              PI lipids have high amounts of chain lengths with 36-38
3                                              PI Z-containing compound heterozygotes (ZS/ZV(R); n = 7)
4                                              PI(4,5)P(2) further retrieves Flower to bulk endosomes,
5                                              PI(4,5)P(2) microdomains drive ADBE and SV reformation f
6                                              PI-4,5-P(2) can be generated by two families of kinases:
7                                              PIs provide efficient elimination of plasmablast-mediate
8 tions provide insights into optimizing HIV-1 PIs containing bis-THF in non-sulfonamide dipeptide isos
9 ces from 483 PR inhibitor (PI)-naive and 232 PI-treated persons; RT sequences from 333 nucleoside RT
10 sports ADAP1 until it encounters high PIP(3)/PI(3,4)P(2) concentrations in the plasma membrane.
11 ligible individuals, 47% started NNRTI-, 30% PI-, and 23% INSTI-based cART with median follow-up of 3
12                       We estimate 2,040 (95% PI, 1,660-2,500), 2,650 (95% PI, 2,030-3,380), and 2,880
13 28% from 6,225 in 2017 to 7,988 in 2030 (95% PI 7,803-8,169), assuming current mortality rates.
14 PI], 2-65), 54 (95% PI, 3-223), and 370 (95% PI, 4-1,850) people infected in the low, moderate, and h
15                     These reach 421,500 (95% PI, 376,300-463,500), 546,800 (95% PI, 499,300-567,000),
16 95% prediction interval [PI], 2-65), 54 (95% PI, 3-223), and 370 (95% PI, 4-1,850) people infected in
17 the projected number increases to 8,579 (95% PI 8,386-8,764).
18 mate 2,040 (95% PI, 1,660-2,500), 2,650 (95% PI, 2,030-3,380), and 2,880 (95% PI, 2,090-3,830) deaths
19 ,500 (95% PI, 376,300-463,500), 546,800 (95% PI, 499,300-567,000), and 589,800 (95% PI, 578,800-595,6
20  (95% PI, 499,300-567,000), and 589,800 (95% PI, 578,800-595,600) people infected in 12 months, respe
21  2,650 (95% PI, 2,030-3,380), and 2,880 (95% PI, 2,090-3,830) deaths in the low, moderate, and high t
22 proteomic approach identified PfHsp70-1 as a PI(3)P-binding protein.
23                       FGF2 oligomerizes in a PI(4,5)P(2)-dependent manner at the inner plasma membran
24 estration of free PI(4)P via expression of a PI(4)P-binding protein in yeast strongly inhibited TBSV
25                 Transcriptome analysis after PI demonstrates broad-scale intron retention, suggestive
26 roposed that signaling-level responses after PI may reveal new mechanisms of action that can be thera
27 veloping novel PIs with high potency against PI-resistant HIV-1 variants with a high genetic barrier.
28                                     Although PI is generally well tolerated, it can be associated wit
29  in remobilization rates, with PI 125840 and PI 137119 increasing remobilization of P under normal P
30 RTI mutations 8.2%, NRTI mutations 4.5%, and PI mutations 0.4%.
31 tation prevalence was 83.6%, NRTI 67.8%, and PI 1.8%.
32 eated with the combination of belatacept and PI therapy, which significantly reduced both class I and
33 tinued having reduced levels of GI, BOP, and PI at Day 60 (P<0.05).
34 RP2 in endothelial cell (EC) cholesterol and PI(4,5)P(2) distribution, angiogenic signaling, and angi
35 2 as a novel regulator of EC cholesterol and PI(4,5)P(2) homeostasis and cholesterol-dependent angiog
36 ropose that the interplay between Flower and PI(4,5)P(2) is the crucial spatiotemporal cue that coupl
37                     Spatially, the E2-I, and PI-E2 transitions were anatomically localized to the ven
38 rafficking, membrane cholesterol levels, and PI(4)P turnover were affected.
39 focal cases, the regions with highest OI and PI corresponded to the side of seizure onset.
40                                       OI and PI were more variable in focal-onset than generalised-on
41 he dual action of Cholesterol (ordering) and PI lipids (disordering).
42 two out of the seven PIPs, namely PI(3)P and PI(3,4)P(2).
43 l deciphering of different commercial PB and PI samples.
44 rization in the case of both Z- and E-PB and PI.
45                      How PI 4-phosphates and PI 3-phosphates are dynamically interconverted within th
46 espiratory phase transitions, E2-I, I-PI and PI-E2.
47 asirox showed a specific increase of ROS and PI-PLCbeta1/Cyclin D3/PKCalpha expression.
48                                Both Sac1 and PI(4)P are recruited to the site of viral replication to
49 demonstrates the novel functions of Sac1 and PI(4)P in TBSV replication in the model host yeast and i
50                         Altogether, Sac1 and PI(4)P play important proviral roles during TBSV replica
51 r signaling seems to be transduced by TK and PI-3K pathways and modulated by CREB, HSF-4a, HDACs, and
52 e on the relationship between FDG uptake and PI.
53  months compared to raltegravir (3.4 kg) and PIs (4.1 kg), though these differences were not statisti
54 ong microtubules, but that PIP(3) as well as PI(3,4)P(2) act as stop signals for this transport inste
55 d oxidative stress and suggest that baseline PI-PLCbeta1 quantification could predict iron chelation
56 eristics, and antimicrobial efficacy between PI 5% and AqCHX 0.1% during IVIs.
57 ndings underscore a mechanistic link between PI(3)P and PfHsp70-1 and present a novel PI(3)P function
58 ed understanding of the relationship between PI availability and the turnover of subcellular PPIn poo
59       Our findings support synergism between PI based desensitization and belatacept facilitating tra
60 etention via an N-terminal domain that binds PI(4,5)P2 and a C-terminal Pex3-binding domain, forming
61 ) and phosphatidylinositol 3,4-bisphosphate (PI(3,4)P(2)).
62 IPs), phosphatidylinositol 4,5-bisphosphate (PI(4,5)P(2)) and phosphatidylinositol 3,4-bisphosphate (
63 ndent phosphatidylinositol 4,5-bisphosphate (PI(4,5)P(2)) compartmentalization governs control of the
64 g how phosphatidylinositol 4,5-bisphosphate (PI(4,5)P(2)) influences ENaC activity and, consequently,
65 ch as phosphatidylinositol 4,5-bisphosphate (PI(4,5)P(2)), are enriched at the cell surface including
66       Phosphatidylinositol-4,5-bisphosphate (PI-4,5-P(2) ) is critical for synaptic vesicle docking a
67 se in phosphatidylinositol 4,5-bisphosphate [PI(4,5)P(2)] levels, which is a major contributor to cha
68 lipid phosphatidylinositol 4,5-bisphosphate [PI(4,5)P(2)].
69                                    When both PI 3-kinase and LC3 lipidation reactions were performed
70 erol (DAG), the product of the PLC-catalyzed PI(4,5)P(2) hydrolysis, activates protein kinase C (PKC)
71 w insights for studies with venom compounds, PIs, and drug design.
72 ast cancer and highlight the need to control PI, a pervasive inflammatory condition in older patients
73  Periplaneta americana cockroach allergen Cr-PI/Per a 3 in ACR and two isoforms of the allergen Api m
74             LRRK2 phosphorylates cytoplasmic PI(3,4,5)P3-positive GTP-Rab10, before EEA1 and Rab5 rec
75                Delta PV (P < .001) and Delta PI (P = .001) were significantly higher among patients w
76 the probability of their patients developing PI-IBS, if available.
77 nfirmed to be a diacylglycerophosphoinositol PI(C18:0/C20:4) via MS/MS using a novel hybrid SIMS inst
78 e of this domain bound to the substrate diC8-PI(3,4,5)P(3), providing the first image of a 5-phosphat
79 roperties of PI solution ensured that dilute PI would not be effective in this study.
80 inicians should prudently consider effective PI application, and we thank Koerner and Grzybowski for
81 naling pathways associated with ER/PR, EGFR, PI(3)K, Hippo, and Wnt in cancer.
82 ting lipid conversion products of endogenous PI after acute chemogenetic activation of PI-specific ph
83 at activating MAPK pathway mutations enhance PI resistance by increasing proteasome capacity, and pro
84 oiting the properties of a bacterial enzyme, PI-specific PLC (PI-PLC).
85                                        (18)F-PI-2620 administration was safe and well tolerated.
86                                        (18)F-PI-2620 binding was assessed visually and quantitatively
87                         Preclinically, (18)F-PI-2620 binds to both 3-repeat and 4-repeat tau isoforms
88                            Conclusion: (18)F-PI-2620 exhibits fast kinetics, suitable dosimetry, and
89 dosimetry, and quantitative methods of (18)F-PI-2620 in the human brain.
90                                        (18)F-PI-2620 is a next-generation tau PET tracer that has dem
91                                        (18)F-PI-2620 is a PET tracer with high binding affinity for a
92 and excellent signal-to-noise ratio of (18)F-PI-2620 PET for imaging tau deposition in AD subjects.
93 althy controls (HCs) underwent dynamic (18)F-PI-2620 PET imaging for 180 min.
94                   SUVR can be used for (18)F-PI-2620 PET quantification of tau deposits, avoiding art
95                                 Static (18)F-PI-2620 PET scans between 45 and 75 min after injection
96                               Results: (18)F-PI-2620 showed peak brain uptake around 5 min after inje
97 s study was to evaluate the ability of (18)F-PI-2620 to detect tau pathology in AD patients using PET
98                                        (18)F-PI-2620 uptake in expected regions correlates strongly w
99                                        (18)F-PI-2620 uptake in neocortical regions significantly corr
100 nly 24.7% of the projects were led by female PIs, who were predominantly nonphysician PhD scientists
101 r PIs characterized to date and is the first PI with CS-alpha/beta motif described from animal venoms
102 , including localizing exogenous fluorescent PI, as well as detecting lipid conversion products of en
103 erved over several weeks to months following PI therapy.
104 estimated a significant financial burden for PI-IBS patients, ranging from $100-1000 (USD) over the c
105 by establishing a positive feedback loop for PI(4,5)P(2) microdomain compartmentalization.
106 -specific biomarker or treatment regimen for PI-IBS currently exists, therefore understanding practic
107                                Treatment for PI-IBS followed IBS recommendations, but most physicians
108 s, Stt4p and Pik1p; or sequestration of free PI(4)P via expression of a PI(4)P-binding protein in yea
109 rom I to post-inspiration (PI), and (3) from PI to E2.
110 e included mechanistic studies of LLPCs from PI-treated patients.
111          The fast GSIS phase was absent from PIs from NOX4-null, beta-cell-specific knockout mice (NO
112 t to signaling endosomes, where it generates PI(3,5)P(2).
113 each of the lipid kinase PIKfyve, generating PI(3,5)P(2) from PI3P and the lipid phosphatase Fig4, re
114 resistance, particularly to first-generation PIs.
115  SH but showed positive correlation with GI, PI, and BOP in both groups.
116 tigated generation of MDA and HHE in herring PI.
117                                          How PI 4-phosphates and PI 3-phosphates are dynamically inte
118                         Here, we explore how PI(3,5)P(2) levels within cells are regulated.
119                                     However, PI(3)P function during the Plasmodium stress response wa
120 three respiratory phase transitions, E2-I, I-PI and PI-E2.
121 We show, for the first time, that only the I-PI transition engages a brainstem-wide network, and that
122                 The probability of identity (PI) for all fish tested was 2.1 x 10(-5) and the PI for
123 ctor, phosphatidylinositol 4-kinase IIIbeta [PI(4)KIIIbeta], in different mammalian cell lines preven
124                                 Peri-implant PI, BOP, PD, and CBL were measured.
125 in the IGP, and underestimated biomass-BC in PI, which contributes to the model-observation bias.
126         This article reviews the concepts in PI-RADS version 2.1 for estimating the probability and z
127 rate that heat-induced DV destabilization in PI(3)P-deficient P. falciparum precedes cell death and i
128 4 overexpression or H(2)O(2) rescued GSIS in PIs from NOX4betaKO mice.
129                    Phosphorus Incorporation (PI, abbreviated Pai) reagents for the modular, scalable,
130  SVs to periactive zones, where it increases PI(4,5)P(2) levels via Ca(2+) influxes.
131  generate seizures; and Participation Index (PI), the tendency of a region to become involved in seiz
132 ange in plaque volume (PV) and plaque index (PI) per year using coronary intravascular ultrasound.
133 ng depth, gingival index (GI), plaque index (PI), and bleeding on probing (BOP) were recorded on full
134       Probing depth (PD), CAL, plaque index (PI), and interproximal bone height were evaluated at bas
135  were evaluated in addition to plaque index (PI), pocket depth, and clinical attachment level at days
136                     Full-mouth plaque-index (PI), bleeding-on-probing (BOP), probing depth (PD), clin
137 ancer, specifically the proliferation index (PI) - the proportion of cells in S, G2 or M phases.
138 AL], marginal bone loss [MBL], plaque index [PI], and bleeding on probing [BOP] in shamma users and n
139 mplant inflammatory variables (plaque index [PI], bleeding on probing [BOP], probing depth (PD) and c
140  C(4)-biomass burning from peninsular India (PI).
141      Mechanistically, osmotic stress induces PI(4,5)P(2) plasma membrane enrichment by activating the
142 ress the effect of periodontal inflammation (PI) on tumor progression, metastasis, and possible under
143 otease (PR) sequences from 483 PR inhibitor (PI)-naive and 232 PI-treated persons; RT sequences from
144 (1 K101E, 2 K103N) and 1 protease inhibitor (PI) SDRM (M46I).
145 ohort initiating INSTI-, protease inhibitor (PI)-, and nonnucleoside reverse transcriptase inhibitor
146 esized that augmenting proteasome inhibitor (PI) based desensitization with costimulation blockade (b
147 ents and contribute to proteasome inhibitor (PI) resistance, but the underlying mechanisms are not fu
148 ncing the efficacy of proteasome inhibitors (PI) is a central goal in myeloma therapy.
149                        Peptidase inhibitors (PIs) have been broadly studied due to their wide therape
150 nalysis of hybrid HIV-1 protease inhibitors (PIs) containing bis-tetrahydrofuran (bis-THF) in a pseud
151 inhibitors (NRTIs), and protease inhibitors (PIs) using Stanford HIVDB 8.8 and SmartGene IDNS softwar
152                   HIV-1 protease inhibitors (PIs), such as darunavir (DRV), are the key component of
153  of second-generation proteasome inhibitors (PIs).
154 sm were observed up to 20 weeks post-injury (PI).
155 attern of inspiration (I), post-inspiration (PI) and late-expiration (E2).
156 iration (I), (2) from I to post-inspiration (PI), and (3) from PI to E2.
157 naive adults (>=18 years) initiating INSTI-, PI-, or NNRTI-based regimens from 01/2007-12/2017 who ha
158  neurons reside in the pars intercerebralis (PI), a neuro-secretory center in the brain involved in h
159 reak, we expect 18 (95% prediction interval [PI], 2-65), 54 (95% PI, 3-223), and 370 (95% PI, 4-1,850
160 s captured through 95% prediction intervals (PI).
161 sent advice to both principal investigators (PIs) and postdocs for successfully navigating a remote p
162                    Principal investigators' (PIs) data were extracted from publicly available informa
163  bifunctional molecule, piperazinium iodide (PI), containing both R(2)NH and R(2)NH(2)(+) groups on t
164 f various concentrations of povidone iodine (PI) solution in an agar plate experiment of respiratory
165                     Topical povidone-iodine (PI) is widely used as an ocular surface antiseptic for i
166 arfilzomib (a second-generation irreversible PI) demonstrated improved efficacy in eliminating BM PCs
167 sulin secretion (GSIS) in pancreatic islets (PIs) of beta-cells through an as yet unknown mechanism.
168 in both herring and salmon protein isolates (PI) while seaweed and shrimp by-product mitigated genera
169 genistein and phosphatidylinositol 3-kinase (PI-3K) inhibitor, wortmannin reversed the ANG II-depende
170 n PhD scientists (52% vs 37.7% PhD-only male PIs; P = 0.002).
171 oductivity, the shutdown has proven for many PIs and trainees that doing and thinking science are not
172 ytically active Fig4 is required for maximal PI(3,5)P(2) production by PIKfyve in vivo.
173  a large number of proteins that can mediate PI signaling.
174 results reveal a function for INPP4-mediated PI(3,4)P(2) hydrolysis in local regulation of growth fac
175 eover, pharmacological elevation of membrane PI(4,5)P2 in cultured neurons impairs SV endocytosis, sp
176 wild-type Protease (PR(WT)) and highly-multi-PI-resistance-associated PR(DRV)(R)(P51) revealed that t
177 ty towards two out of the seven PIPs, namely PI(3)P and PI(3,4)P(2).
178 een PI(3)P and PfHsp70-1 and present a novel PI(3)P function in DV stabilization during heat stress.
179 work provides the basis for developing novel PIs with high potency against PI-resistant HIV-1 variant
180                            Here, seven novel PIs were synthesized, by introducing single atom changes
181 us PI after acute chemogenetic activation of PI-specific phospholipase and 4-kinase.
182 an survey respondents (n = 50) were aware of PI-IBS, but less than half discussed this condition as a
183  is primarily exerted through the control of PI(4,5)P(2) production by type-I phosphatidylinositol-4-
184 aches to map the subcellular distribution of PI, including localizing exogenous fluorescent PI, as we
185  disease cohort, we confirmed the effects of PI Z heterozygote and compound heterozygote genotypes.
186 so led to demonstration of the enrichment of PI(4)P phosphoinositide within the replication compartme
187 ly connected as Fab1-dependent generation of PI(3,5)P(2) supports TORC1 activity.
188 ed a molecular toolbox for investigations of PI distribution within intact cells by exploiting the pr
189       However, there is a surprising lack of PI in the plasma membrane compared with the PPIn.
190  only detect very low steady-state levels of PI within the plasma membrane (PM) and endosomes.
191 chelation therapy displayed higher levels of PI-PLCbeta1/Cyclin D3/PKCalpha expression.
192  interference as an unrecognized modality of PI mechanism, reveal additional modes of spliceosome mod
193 ing these tools, we find a minor presence of PI in membranes of the ER, as well as a general enrichme
194 design and the pharmacokinetic properties of PI solution ensured that dilute PI would not be effectiv
195  Deferasirox, showed a specific reduction of PI-PLCbeta1/Cyclin D3/PKCalpha expression, indicating th
196 r of predictions regarding the regulation of PI cycle enzymes, the importance of the number of recept
197    These experiments implicate regulation of PI supply to the plasma membrane, as opposed to regulati
198                       Rationale: The role of PI (protease inhibitor) type Z heterozygotes and additio
199  sensing by TRPM8 and the allosteric role of PI(4,5)P(2) in agonist binding for TRPM8 activation.
200 s no significant difference in the scores of PI, BOP, PD, clinical AL and MBL when SRP was performed
201 ipulations, we found that local synthesis of PI(3,4)P(2) by phosphatidylinositol 3-kinase C2alpha at
202 e size, physician knowledge and treatment of PI-IBS was consistent across respondents.
203 to understand the knowledge and treatment of PI-IBS within the physician's current practice.
204 st a model whereby synthesis and turnover of PI(3,4)P(2) are spatially segregated within the endocyti
205                                  A series of PIs were synthesized by incorporating bis-THF of darunav
206 recruitment of WIPI2 that in turn depends on PI(3)P.
207 tations and associates with their effects on PI(4,5)P(2) levels, however, with the exception of the A
208              In accord with their effects on PI(4,5)P(2) levels, the PD associated A30P, E46K, and A5
209 es of iron effect and Deferasirox therapy on PI-PLCbeta1 inositide signaling, using hematopoietic cel
210 osomes but not to PI5P-deprived liposomes or PI-containing liposomes.
211 e for targeting such patients with PI/RAF or PI/MEK inhibitor combinations.
212 nitiating first cART regimens with INSTIs or PIs vs. NNRTIs may confer greater risk of DM, likely med
213 PI1 shares no sequence similarity with other PIs characterized to date and is the first PI with CS-al
214      Abrupt perturbations to Ras, PI(4,5)P2, PI(3,4)P2, ERK, and TORC2 alter the threshold, observati
215                      Periodontal parameters (PI, BOP, PD, clinical AL and mesial and distal MBL) were
216 hibitor and knockdown of PfHsp70-1 phenocopy PI(3)P-deficient parasites under heat shock.
217            Phosphatidylinositol 3-phosphate (PI(3)P) levels in Plasmodium falciparum correlate with t
218 sterol and phosphatidylinositol 4-phosphate (PI(4)P), between organelle membranes.
219 effects by phosphatidylinositol-3-phosphate [PI(3)P] and ergosterol on TBSV replication.
220 domains of phosphatidylinositol 4-phosphate [PI(4)P] on trans-Golgi network (TGN) vesicles were recru
221 on of Sac1 phosphatidylinositol 4-phosphate [PI(4)P] phosphatase reduced tomato bushy stunt virus (TB
222 the lipid, phosphatidylinositol-4-phosphate [PI(4)P].
223                        Phosphatidylinositol (PI) is an essential structural component of eukaryotic m
224      It is unclear how phosphatidylinositol (PI), the precursor of polyphosphoinositides, is distribu
225 ajor structural lipid, phosphatidylinositol (PI).
226       In mycobacteria, phosphatidylinositol (PI) acts as a common lipid anchor for key components of
227 th elevated amounts of phosphatidylinositol (PI), were also present.
228                    The phosphatidylinositol (PI) cycle is central to eukaryotic cell signaling.
229 d cell signaling, with phosphatidylinositol (PI) 3-phosphates being the predominant phosphoinositide
230 s its substrate lipid (phosphatidylinositol, PI) to generate the essential signaling lipid phosphatid
231 lceramides (LCER) and phosphatidylinositols (PI) were also detected in the BM plasma samples from MM
232 phosphatidylcholines, phosphatidylinositols (PI) and cholesterol.
233            Synthesis of the phosphoinositide PI(3)P by the autophagic class III phosphatidylinositol-
234                         The phosphoinositide PI(3,5)P(2), generated exclusively by the PIKfyve lipid
235 g messenger, NAADP and the phosphoinositide, PI(3,5)P(2), respectively.
236                           Phosphoinositides (PI) are key regulators of cellular organization in eukar
237 rosecretory cells by binding to phospholipid PI(4,5)P(2) However, unlike synaptrobrevin-2, the SNARE
238  is their ability to act as photoinitiators (PIs) for radical polymerization.
239 ties of a bacterial enzyme, PI-specific PLC (PI-PLC).
240 chemical connection between Galphaq/PLCbeta /PI(4,5)P(2) that couples calcium responses with neural p
241 individual components of the Galphaq/PLCbeta/PI(4,5)P(2) pathway during retraction and correlated the
242 nstrate that ORP2 depletion increases the PM PI(4,5)P(2) coincident with altered F-actin morphology,
243         Polybutadiene (PB) and polyisoprene (PI), the two most common polydienes (PD), are involved i
244 d on the buccal of the mandibular premolars (PI and PII).
245  in different mammalian cell lines prevented PI(4)P generation and led to a hyperfused and branched m
246 ces accumulation of OsPIP5K1 and its product PI(4,5)P(2) , a phosphoinositide secondary messenger, in
247 tocatalysts, review their studies as Quantum PIs for radical polymerization, from suspension polymeri
248 troduction of the next generation of Quantum PIs.
249 as photoinitiators, coining the term Quantum PIs, and provided insights for their photocatalytic mech
250                 Abrupt perturbations to Ras, PI(4,5)P2, PI(3,4)P2, ERK, and TORC2 alter the threshold
251                           Eyes that received PI had a higher ocular staining score indicating worse c
252          Compared with AqCHX, eyes receiving PI had a greater mean pain score immediately after injec
253 ncreased, and this enhanced capacity reduced PI sensitivity, while DN-KRAS and DN-NRAS did the opposi
254 th adjunct PT was more effective in reducing PI (P < 0.05), BOP (P < 0.05) and PD (P < 0.05) at 3-mon
255                                  Remarkably, PI(4,5)P(2) directly enhances Flower channel activity, t
256 BSV, we uncovered the critical roles of Sac1 PI(4)P phosphatase and its substrate, PI(4)P phosphoinos
257                                   The salmon PI, however, by itself had very low oxidation levels.
258 e of phosphoinositide dynamics, specifically PI(4,5)P(2), in Hippo pathway regulation.
259 f Sac1 PI(4)P phosphatase and its substrate, PI(4)P phosphoinositide, in promoting viral replication.
260 e contain elevated 5'-phosphatase substrate, PI(4,5)P2, particularly in the midbrain neurons.
261 so demonstrate the requirement for sustained PI supply from the ER for the maintenance of monophospho
262    Post-infectious Irritable Bowel Syndrome (PI-IBS) is a functional bowel disorder which has signifi
263 of post-infectious Irritable Bowel Syndrome (PI-IBS).
264                     Thus, recruitment of TGN-PI(4)P-containing vesicles at mitochondria-ER contact si
265                               We report that PI is broadly distributed throughout intracellular membr
266 chemical and genetic reporters revealed that PI(3)P stabilizes the digestive vacuole (DV) under heat
267               All in all, our data show that PI-PLCbeta1 signaling is a target for iron-induced oxida
268 for all fish tested was 2.1 x 10(-5) and the PI for siblings (PIsib) was 6.4 x 10(-3), as calculated
269         Importantly, Piezo(+) neurons at the PI are activated directly by crop distension, thus conve
270 tially segregated from its hydrolysis by the PI(3,4)P(2)-specific inositol polyphosphate 4-phosphatas
271 stem-wide network, and that rLFPs during the PI-E2 transition identify a hitherto unknown role for th
272                             Reduction in the PI(4)P level due to chemical inhibition in plant protopl
273     TGFbeta increased phosphorylation of the PI 3-kinase-interacting Tyr-751 residue of PDGFRbeta, th
274      In this work, we develop a model of the PI cycle informed by experimental and omics data taken f
275 hanced foaming gel significantly reduced the PI in Group 1 at Day 42 compared to control and un-floss
276 d phosphoproteomics after treatment with the PI carfilzomib surprisingly demonstrates the most promin
277             X-ray structural analyses of the PIs complexed with wild-type Protease (PR(WT)) and highl
278                             The color of the PIs varied greatly between different process combination
279 associated PR(DRV)(R)(P51) revealed that the PIs better adapt to structural plasticity in PR with res
280                           Furthermore, these PIs displayed increased cell permeability and extreme an
281 endocytosis is specifically mediated through PI(4,5)P(2) levels on the plasma membrane.
282  CD40-induced Ras-mediated signaling through PI-3K and Raf-1.
283 ine may be a better tolerated alternative to PI for antimicrobial prophylaxis during IVIs for some pa
284  impacts to patient's quality of life due to PI-IBS.
285         Each patient had 1 eye randomized to PI or AqCHX, and the second eye received the other agent
286 ent DM risk (HR=1.17 [0.92-1.48]) similar to PI- vs. NNRTI-initiators (HR=1.27 [1.07-1.51]).
287 ase from 12.4% to 31.7% in grants awarded to PIs with >15 years of experience.
288                       Strong stimuli trigger PI(4,5)P(2) microdomain formation at periactive zones.
289 ganization in eukaryotes and genes that tune PI signaling are implicated in human disease mechanisms.
290 ition in plant protoplasts; depletion of two PI(4)P kinases, Stt4p and Pik1p; or sequestration of fre
291 evels of apoptosis, as assessed by annexin V/PI assays and increased caspase 3/7 activity in MDA-MB-2
292  BE(2)-C cells was demonstrated by Annexin V/PI staining.
293 ion of photoreceptor cells at 4 and 10 weeks PI.
294 e lipids at endosomes and lysosomes, whereas PI 4-phosphates, such as phosphatidylinositol 4,5-bispho
295 ERPINA1.Measurements and Main Results: White PI Z heterozygotes confirmed by sequencing (MZ; n = 74)
296 adopt varying strategies for antisepsis with PI, which to this day remains efficient, economical and
297 tion mimicking that of early endosomes, with PI(3)P enhancing membrane recruitment of Rab5 and acyl c
298 ta production were detected in patients with PI, mirrored in mouse models.
299 a rationale for targeting such patients with PI/RAF or PI/MEK inhibitor combinations.
300 owed variation in remobilization rates, with PI 125840 and PI 137119 increasing remobilization of P u
301 ompared with 1,411 white individuals without PI Z, S, or additional rare variants denoted as V(R).

 
Page Top